RYNE BIOTECHNOLOGY
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.
RYNE BIOTECHNOLOGY
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2022-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ryne-bio.com
Total Employee:
1+
Status:
Active
Contact:
815-505-6466
Total Funding:
3 M USD
Official Site Inspections
http://www.ryne-bio.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Ryne Biotechnology"
Ryne Bio - Org Chart, Teams, Culture & Jobs - The Org
Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders. To achieve this they leverage …See details»
Ryne Bio - VentureRadar
" Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.To achieve this we leverage …See details»
Kenai Emerges from Stealth With $82M Series A, Targets Parkinson’s
Mar 1, 2024 Pictured: 3D illustration of stem cells used for cell therapy/iStock, Maksim Tkachenko San Diego-based Kenai Therapeutics announced its arrival on the biotech scene …See details»
Ryne Bio - Company Profile - Tracxn
Feb 16, 2023 Ryne Bio ranks 9th among 40 active competitors. 17 of its competitors are funded while 2 have exited. Overall, Ryne Bio and its competitors have raised over $659M in funding …See details»
Kenai Therapeutics - Products, Competitors, Financials, Employees ...
The company primarily sells to sectors involved in neurological health, clinical research, and regenerative medicine. Kenai Therapeutics was formerly known as Ryne Bio. It was founded …See details»
Jonathan Yeh - Co-founder & Board Observer at Ryne Bio - The Org
Co-founder & Board Observer at Ryne Bio. Contact. Jonathan Yeh is a seasoned venture capital professional and biomedical entrepreneur with significant experience in investment and …See details»
Kenai Therapeutics - Crunchbase Company Profile & Funding
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders. The company provides off-the-shelf neuron replacement medicines as effective disease …See details»
Ryne Biotechnology Information - RocketReach
Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders. To achieve this we leverage …See details»
Cure Ventures backs a cell therapy startup targeting Parkinson’s
Feb 29, 2024 Previously known as Ryne Bio, Kenai’s research aim is to create so-called off-the-shelf cell therapies that replace neurons. The company’s most advanced medicine is made …See details»
Ryne Biotechnology Awarded $4 Million from the California …
Feb 14, 2023 SAN DIEGO — Ryne Biotechnology, Inc. (Ryne Bio), a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform …See details»
Ryne Bio - VentureRadar
Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.To achieve this we leverage …See details»
New biotech company focused on cell transplantation for …
Feb 15, 2023 Biotech company Ryne Bio has received a large research grant to develop their late-stage preclinical cell transplantation procedure for Parkinson’s. The California Institute for …See details»
Biotalk Episode 7: A Conversation with Howard Federoff of Ryne ...
Aug 30, 2023 On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Howard Federoff, MD PhD, Scientific Co-Founder, Chief Medical Officer, and Director of Ryne …See details»
Ryne Biotechnology Wins $4M from CIRM to Develop RNDP-001, …
February 14, 2023, San Diego, California — Ryne Biotechnology, Inc. (Ryne Bio), a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop …See details»
Ryne Biotechnology Awarded $4 Million Grant - Medtech Alert
Feb 15, 2023 Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement …See details»
BIOTECH (127) Kenai Therapeutics: Allogeneic iPSC-Induced …
Mar 12, 2024 Ryne Biotechnology, Inc. (Ryne Bio), a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf …See details»
Ryne Biotechnology Awarded $4 Million from the California …
Feb 15, 2023 Ryne Biotechnology, Inc. (Ryne Bio), a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf …See details»
Neuron replacement therapy for Parkinson’s moves to clinical trial
San Diego-based Ryne Biotechnology announced last week that it has received a $4 million Clinical Stage Research Program grant from the California Institute for Regenerative Medicine …See details»
RYNE – we are a leading pharmaceutical marketing company
Ryne Bio Life Sciences has been a game-changer for our pharmacy. Their innovative products and commitment to quality have allowed us to offer our customers effective solutions for their …See details»
Ryne Bio | VentureRadar
Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.To achieve this we leverage …See details»